Gene and Cell Therapy

Baylor College of Medicine, Houston, TX, USA

Delivery Systems and Therapeutic Strategies
Retroviral Vectors for Cell and Gene Therapy, A. Schambach, T. Maetzig, and C. Baum
Production of Retroviral Vectors: From the Producer Cell to the Final Product, P.E. Cruz, A.S. Coroadinha, T. Rodrigues, and H. Hauser
Adenovirus Vectors for Gene Therapy, N.R. Hackett and R.G. Crystal
Modified Adenoviruses for Gene Therapy, J.N. Glasgow, A. Hemminki, and D.T. Curiel
Helper-Dependent Adenoviral Vectors for Gene Therapy, N. Brunetti-Pierri and P. Ng
Adeno-Associated Virus and AAV Vectors for Gene Delivery, B.J. Carter, H. Burstein, and R.W. Peluso
Therapeutic Gene Transfer with Replication-Defective Herpes Simplex Viral Vectors, D. Wolfe, W.F. Goins, A. Frampton, M. Mata, D.J. Fink, and J.C. Glorioso
Oncolytic Viruses for Treatment of Cancer, M. Raki, M. Rajecki, D. Kirn, and A. Hemminki
Lentiviral Vectors, J.M. Felder III and R. Sutton
Vaccinia Viral Vectors, J.A. McCart and D.L. Bartlett
Baculovirus-Mediated Gene Transfer: An Emerging Universal Concept, K.J. Airenne, A.J. Mähönen, O.H. Laitinen, and S. Ylä-Herttuala
Bacterial Vector in Gene Therapy, M.-S. Dai and G. Vassaux
Redox-Responsive Polymer-Based Gene Delivery Systems, D. Oupicky, Y.-Z. You, and D.S. Manickam
Polymers and Dendrimers for Gene Delivery in Gene Therapy, I.F. Uchegbu, C. Dufès, P.L. Kan, and A.G. Schätzlein
Receptor-Targeted Polyplexes for DNA and siRNA Delivery, A. Philipp and E. Wagner
Electroporation of Plasmid-Based Vaccines and Therapeutics, R. Draghia-Akli and A.S. Khan
Magnetofection: Using Magnetic Particles and Magnetic Force to Enhance
and to Target Nucleic Acid Delivery, F. Scherer and C. Plank
Biolistic and Other Needle-Free Delivery Systems, M.A.F. Kendall
Optimization of Nonviral Gene Therapeutics, N. Smyth Templeton
Photochemical Internalization: A Technology for Efficient and Site-Specifi c Gene Delivery, A. Bonsted, A. Høgset, and K. Berg
Interactions in Macromolecular Complexes Used as Nonviral Vectors for Gene Delivery, R. Podgornik, D. Harries, J. DeRouchey, H.H. Strey, and V.A. Parsegian
Other Therapeutic Strategies
In vivo Applications of Morpholino Oligonucleotides, J.S. Isenberg, W.A. Frazier, and D.D. Roberts
Antisense Oligonucleotide-Based Therapeutics, C.F. Bennett, E. Swayze, R. Geary, L. Tillman, and G. Hardee
Development of RNAi Therapeutics, A.R. de Fougerolles
Suicide Gene Therapy, N. Ballian, B.W. O’Malley Jr., and F.C. Brunicardi
Selectable Markers for Gene Therapy, J.-P. Gillet, C. Kimchi-Sarfaty, S. Shinar, T. Licht, C. Lee, P. Hafkemeyer, C.A. Hrycyna, I. Pastan, and M.M. Gottesman
Embryonic Stem Cells and Their Application in Regenerative Medicine and Tissue Engineering,.D. Evans and J.M. Polak
Polymeric Nano- and Microparticles for the Delivery of Antisense Oligonucleotides and siRNA, E. Fattal and G. De Rosa
Gene Expression and Detection
Deliberate Regulation of Therapeutic Transgenes, N. Vilaboa and R. Voellmy
Monitoring Gene and Cell Therapies in Living Subjects with Molecular Imaging Technologies, S. Ray, S. Biswal, and S.S. Gambhir
Nonviral Genome Modification Strategies for Gene Therapy: Transposon, Integrase,
and Homologous Recombination Systems, L.E. Woodard and M.P. Calos
Disease Targets and Therapeutic Strategies
Hematopoietic Progenitor Cells, K.-Y.K. Lin, O. Sirin, and M.A. Goodell
Gene Therapy for Hematopoietic Disorders,.M. Kang, M.E. Horwitz, and H.L. Malech
Use of Genetically Modified Stem Cells in Experimental Gene Therapies, T.P. Zwaka
Cardiovascular Gene and Cell Therapy, K. Oka
Gene Therapy for Cancer, K. Brand
Molecular Therapy for Type 1 and Type 2 Diabetes, S.L. Samson, V. Yechoor, and L. Chan
Progress toward Gene Therapy for Cystic Fibrosis, R.S. Everett and L.G. Johnson
Gene Therapy for Neurological Diseases, W.J. Bowers, S. de Silva, and H.J. Federoff
Principles of Gene Therapy for Inborn Errors of Metabolism, J.A. Wolff and C.O. Harding
RNA Interference–Based Gene Therapy Strategies for the Treatment of HIV Infection, L. Scherer and J.J. Rossi
Cutaneous Gene Transfer: Cell and Gene Therapy of Skin and Systemic Disorders, W. Buitrago and D.R. Roop
Gene Therapy for Childhood Onset Blindness, M.C. Canver and J. Bennett
DNA Vaccines, J. Yan and D.B. Weiner
Immunoisolation for CNS Cell Therapy, D.F. Emerich and C.G. Thanos
Clinical Trials and Regulatory Issues
Cardiovascular Gene Therapy, J. Tongers, J. Roncalli, and D.W. Losordo
Gene Therapy for the Treatment of Cancer: From Laboratory to Bedside, G. Dotti, B. Savoldo, F. Okur, R.F. Rousseau, and M.K. Brenner
p53 Tumor Suppressor Opens Gateways for Cancer Therapy, M.-S. Dai, J.R. Gallegos, and H. Lu
Recombinant Adenoviral-p53 Agent for Treatment of Cancers, Z. Peng, Q. Yu, and J. Zhu
Gene Marking Studies of Hematopoietic Cells, C.M. Bollard, S.K. Tey, M.K. Brenner, and H.E. Heslop
Regulatory Aspects of Gene Therapy, S.L. Simek and L. Bi
Index